2018-07-24T05:42:33
AIDAN Approaches DTAB To Remove Non-Experts From FDC Panel, Seeks More Time To Submit Data (19-03-2018)
New Delhi, 19 March 2018: As a sub-committee of the Drugs Technical Advisory Board (DTAB) gets ready to examine the ban on 300-plus fixed dose combination (FDC) drugs, All India Drug Action Network (Aidan), a petitioner in the case, has come out against the presence of ‘non-expert’ members in the panel and the tight deadline set by the government to make submissions.
In a letter written on March 15 to DTAB chairman Dr BD Athani, which has been reviewed by Pharmabiz, Aidan sought the removal of ‘non-expert’ industry body representatives and professional association members from the sub-committee citing credibility issues and conflict of interest. The group, a network of NGOs in the health sector, called for the reconstitution of the panel to increase its reliability.
The non-profit organisation also wanted the technical advisory board to extend the deadline for submissions by another month as more than 1, 000 formulations related to the 344 impugned FDCs need
Have a question? Ask here!
Required fields are marked *